Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Hormones – e.g. – prolactin – thymosin – growth factors – etc.
Reexamination Certificate
2007-05-08
2007-05-08
Spector, Lorraine (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Hormones, e.g., prolactin, thymosin, growth factors, etc.
C514S012200, C435S069500
Reexamination Certificate
active
10773654
ABSTRACT:
The growth hormone supergene family comprises greater than 20 structurally related cytokines and growth factors. A general method is provided for creating site-specific, biologically active conjugates of these proteins. The method involves adding cysteine residues to non-essential regions of the proteins or substituting cysteine residues for non-essential amino acids in the proteins using site-directed mutagenesis and then covalently coupling a cysteine-reactive polymer or other type of cysteine-reactive moiety to the proteins via the added cysteine residue. Disclosed herein are preferred sites for adding cysteine residues or introducing cysteine substitutions into the proteins, and the proteins and protein derivatives produced thereby.
REFERENCES:
patent: 4588585 (1986-05-01), Mark et al.
patent: 5166322 (1992-11-01), Shaw et al.
patent: 5206344 (1993-04-01), Katre et al.
patent: 5208158 (1993-05-01), Bech et al.
patent: 5229496 (1993-07-01), Deeley et al.
patent: 5391485 (1995-02-01), Deeley et al.
patent: 5393870 (1995-02-01), Deeley et al.
patent: 5602007 (1997-02-01), Dunn et al.
patent: 5720952 (1998-02-01), Clark et al.
patent: 5766897 (1998-06-01), Braxton
patent: 5849535 (1998-12-01), Cunningham et al.
patent: 5891429 (1999-04-01), Clark et al.
patent: 5895646 (1999-04-01), Wang
patent: 5908763 (1999-06-01), Clark et al.
patent: 5942221 (1999-08-01), Clark et al.
patent: 0 458 064 (1991-11-01), None
patent: WO 93/00109 (1993-07-01), None
patent: WO 95/11987 (1995-04-01), None
patent: WO 95/32003 (1995-11-01), None
patent: WO 96/31537 (1996-10-01), None
Zurawski et al. Embo Journal 12, 5113-5119.
Bazan JF Science 257: 410-412.
Bazan,Immunology Today, 11:350-354 (1990).
Campbell et al.,J. Peptide Res., 49:527-537 (1997).
Cunningham et al.,Science, 243:1330-1336 (1989).
Goodson and Katre,Bio/Technology, 8:343-346 (1990).
Karpusas et al.,Proc. Natl. Acad. Sci. USA, 94:11813-11818 (1997).
Lowman and Wells,J. Mol. Biol., 234:564-578 (1993).
Mott and Compbell,Curr Opin Struct Biol, 5:114-121 (1995).
Sprang and Bazan,Curr. Op. Struct. Biol., 3:815-827 (1993).
Walter et al.,J. Mol. Biol., 224:1075-1085 (1992).
Wells,Ann. Rev. Biochem., 65:609-634 (1996).
Zalipsky, S.,Adv. Drug Delivery Rev., 16:157-182 (1995).
Bolder Biotechnology Inc.
Sheridan & Ross P.C.
Spector Lorraine
Stoica Elly-Gerald
LandOfFree
Termini cysteine-added variants of granulocyte-macrophage... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Termini cysteine-added variants of granulocyte-macrophage..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Termini cysteine-added variants of granulocyte-macrophage... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3768537